SoundHealth pairs smartphone facial scanning with a large craniofacial anatomical dataset to personalize acoustic resonant frequencies for each user. That personalization underpins both medical and wellness applications on a shared AI and hardware stack.
SONU holds FDA clearance for drug-free treatment of allergic and non-allergic rhinitis in ages 12 and up, with more than 500,000 treatment sessions delivered and recommendations from more than 1,000 medical and dental professionals.
Demand for non-pharmaceutical options for chronic rhinitis and sleep disorders continues to rise as patients and clinicians look beyond long-term steroid sprays and sedative sleep aids. Population-scale breathing and sleep conditions remain large addressable markets for validated device-based alternatives.
Series A capital is directed at accelerating SONU commercialization and expanding personalized acoustic therapy into sleep wellness channels across the United States.
The commercial portfolio centers on the SONU Band, an FDA-cleared headband that delivers personalized acoustic vibration for nasal congestion relief through a companion facial-scan app. SONU is sold direct-to-consumer and is also positioned for ENT, allergy, sleep, and dental airway practices.
Spatial Sleep applies the same craniofacial mapping approach to a sleep headband intended to help users fall asleep faster and sleep longer, extending the platform from rhinitis care into acoustic sleep wellness.